Wanguiyuan Precision Medical
A comprehensive equipment service provider that provides technology, core equipment and overall solutions for in vitro diagnostics & medical high-value consumables manufacturers.
| Date | Investors | Amount | Round |
|---|---|---|---|
| investor | €0.0 | round | |
| investor investor investor | €0.0 | round | |
* | CNY50.0m | Series A | |
| Total Funding | 000k | ||
Related Content
Suzhou Wanguiyuan Precision Technology Co., Ltd., established in 2018, operates as a specialized contract development and manufacturing organization (CDMO) and contract manufacturing organization (CMO) within the HealthTech and medical manufacturing sectors. The company is strategically based in Suzhou, China, a hub for technological and biomedical advancements.
The firm's business model is centered on providing integrated biomedical engineering solutions to a client base of in-vitro diagnostic (IVD) and high-value medical consumables manufacturers. It generates revenue by offering a suite of services that spans from initial design to full-scale production. This includes reagent and microfluidic chip design, the development and manufacturing of molecular diagnostic instruments, and the production of custom automation equipment and consumables.
Wanguiyuan's product portfolio is organized into four distinct series: microfluidic chip-related equipment, reagent-potting systems, sterile automation equipment, and a range of IVD instruments. Key offerings highlighted are its microfluidic chip full-flow automated production workstations and fully enclosed sterile isolated automated preparation systems, which address critical needs for precision and sterility in diagnostics manufacturing. The company also provides custom foundry services for various biochips, including digital PCR and centrifugal disc chips.
Financially, the company has demonstrated significant progress, culminating in a Series A+ funding round in February 2024 that raised CNY 50 million. This capital is earmarked for enhancing the research, development, and production capacities of its microfluidic chip CDMO services, building new R&D bases, and accelerating its expansion into the global market. The company's achievements have been recognized through accolades such as being named a National High-Tech Enterprise.
Keywords: CDMO, CMO, in-vitro diagnostics, IVD, medical consumables, microfluidics, biochips, HealthTech, medical devices, automation equipment, molecular diagnostics, reagent manufacturing, Suzhou, biomedical engineering, Series A, contract manufacturing, laboratory automation, diagnostic instruments, chip design, sterile manufacturing